Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$100,629,074
-$4,564,314 QoQ
Shares Held
399,893
-17.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#253
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$3,786,648
PutShares
20,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $812,352,405 across 9 Drug Manufacturers - General names. ABBV ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
283,001 | $339,439,917 | |
| 2 | JNJ |
Johnson & Johnson
|
647,222 | $164,374,971 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
399,893 | $100,629,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
650,503 | $83,589,635 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
356,488 | $45,038,693 | |
| 6 | PFE |
Pfizer Inc
|
1,753,548 | $42,225,435 | |
| 7 | AMGN |
Amgen Inc
|
68,480 | $24,797,977 | |
| 8 | BIIB |
Biogen Inc.
|
34,879 | $7,535,956 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,629,074 | 399,893 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $105,193,388 | 483,670 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $106,542,602 | 466,290 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $104,385,641 | 450,832 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,786,648 | 20,400 | Put | Sole | 2025-08-08 | |
| 2025-06-30 | $87,244,741 | 470,018 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $105,128,964 | 501,761 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $78,772,810 | 443,291 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $87,439,009 | 442,774 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $77,098,926 | 449,504 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $83,876,898 | 460,609 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $72,598,485 | 468,468 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $70,413,857 | 472,386 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $63,566,691 | 471,808 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $75,222,958 | 472,002 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $83,331,772 | 515,635 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $78,515,802 | 585,022 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $98,938,296 | 645,980 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $102,661,993 | 633,286 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $74,016,816 | 546,653 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $57,327,619 | 531,451 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $52,877,383 | 469,437 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $28,775,806 | 265,901 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $27,622,627 | 257,794 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $23,580,454 | 269,214 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $28,747,889 | 292,808 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $19,664,181 | 258,094 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||